Drug: TYSABRI Injury: Cognitive disorder Quarter: 2016Q3
Total Records: 42 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
89800835 | TYSABRI | Cognitive disorder | NOVARTIS | 35.07 YR | F | 0 | 20160812 | AU |
118727434 | TYSABRI | Cognitive disorder | BIOGEN | 65.02 YR | F | 0 | 20160912 | FR |
120106713 | TYSABRI | Cognitive disorder | BIOGEN | 58.07 YR | F | 0 | 20160801 | US |
122506253 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160728 | US |
122667843 | TYSABRI | Cognitive disorder | BIOGEN | 28.62 YR | F | 0 | 20160727 | US |
123107534 | TYSABRI | Cognitive disorder | BIOGEN | 52.39 YR | F | 0 | 20160811 | BR |
124089274 | TYSABRI | Cognitive disorder | BIOGEN | 53.92 YR | F | 0 | 20160725 | US |
125236001 | TYSABRI | Cognitive disorder | BIOGEN | 37.58 YR | F | 65 KG | 20160703 | US |
125241081 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160704 | US |
125348931 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | M | 0 | 20160707 | US |
125430691 | TYSABRI | Cognitive disorder | BIOGEN | 50.34 YR | F | 0 | 20160710 | US |
125498732 | TYSABRI | Cognitive disorder | BIOGEN | 31.95 YR | F | 0 | 20160725 | NZ |
125564632 | TYSABRI | Cognitive disorder | BIOGEN | 45.28 YR | F | 0 | 20160728 | NZ |
125593201 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160715 | US |
125643711 | TYSABRI | Cognitive disorder | BIOGEN | 41.48 YR | F | 0 | 20160718 | US |
125705242 | TYSABRI | Cognitive disorder | BIOGEN | 55.27 YR | F | 0 | 20160825 | US |
125730611 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160720 | US |
125773431 | TYSABRI | Cognitive disorder | BIOGEN | 31.40 YR | F | 0 | 20160720 | BR |
125992811 | TYSABRI | Cognitive disorder | BIOGEN | 32.65 YR | F | 0 | 20160727 | US |
126011221 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160728 | US |
Total Records: 42 Number of Pages: 3